Security Snapshot

KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) Institutional Ownership

CUSIP: 48669G105

13F Institutional Holders and Ownership History from Q4 2017 to Q1 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / American Depositary Shares
Symbol
KZIA on Nasdaq
Shares outstanding
11,425,388
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares is tracked under CUSIP 48669G105.
  • Latest finished 13F holder period is not available.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 0 to 0 between Q4 2024 and Q1 2025.
  • Reported value moved from $0 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

48669G105

Latest holder period

n/a

13F holders

13D/G owners

3

CIK / CUSIP context first

KZIA full holder history KAZIA THERAPEUTICS LTD SEC filings KAZIA THERAPEUTICS LTD company facts KAZIA THERAPEUTICS LTD insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Significant Owners of KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Chernett Jorey 14% +12% 1,588,129 +12% Chernett Jorey 24 Mar 2026
Alumni Capital LP 10% 0% 178,591 -77% Alumni Capital LP 31 Jul 2025
Dauntless Investment Group, LLC 0% -99% 1 -100% Dauntless Investment Group, LLC 31 Dec 2025

Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$215 0
2024 Q4 0 $0 -$915,427 0
2024 Q3 2,129,596 $915,427 +$790,699 $0.43 16
2024 Q2 391,517 $89,517 -$8,321 $0.23 11
2024 Q1 371,232 $115,509 -$1,994,451 $0.31 11
2023 Q4 4,883,338 $2,151,708 +$2,045,684 $0.44 17
2023 Q3 237,143 $235,867 -$50,263 $1.00 10
2023 Q2 284,444 $327,598 +$11,438 $1.16 9
2023 Q1 271,491 $279,385 -$133,640 $1.03 8
2022 Q4 426,146 $262,014 -$39,908 $0.61 9
2022 Q3 480,663 $527,000 +$2,168 $1.10 6
2022 Q2 294,297 $1,235,000 -$433,172 $4.20 10
2022 Q1 375,986 $2,896,000 -$805,894 $7.86 10
2021 Q4 475,552 $4,007,000 +$165,915 $8.43 10
2021 Q3 539,906 $5,029,362 +$81,288 $11.33 14
2021 Q2 536,161 $4,344,316 +$396,634 $9.87 12
2021 Q1 467,061 $4,601,637 -$368,945 $12.39 12
2020 Q4 529,082 $3,747,276 +$1,082,695 $8.64 12
2020 Q3 442,094 $2,314,216 +$887,634 $6.75 10
2020 Q2 309,803 $723,108 +$170,070 $3.35 6
2020 Q1 260,799 $472,093 +$31,229 $2.90 6
2019 Q4 249,972 $670,139 -$8,525 $4.34 7
2019 Q3 253,418 $568,120 +$72,875 $3.75 7
2019 Q2 227,122 $324,083 +$51,992 $2.42 7
2019 Q1 205,065 $365,107 -$27,520 $3.34 5
2018 Q4 216,716 $293,078 -$12,948 $2.39 6
2018 Q3 220,931 $400,102 +$60,526 $3.24 8
2018 Q2 110,632 $1,746,095 +$33,415 $2.97 7
2018 Q1 94,669 $531,180 +$56,759 $5.61 6
2017 Q4 84,629 $269,000 +$269,000 $3.19 4
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .